Which has grown faster, MRNA or MTD?

Over the past five years, MTD grew revenue faster — MRNA at a -2.60% CAGR versus MTD at 4.77%.

Is MRNA or MTD more profitable?

MTD runs the higher net margin — MRNA at -143.55% versus MTD at 21.40%.

Which has been the better investment, MRNA or MTD?

Over the past 5-year, MTD delivered the higher annualized total return — MRNA at -25.58% versus MTD at 11.59%. Past performance doesn't predict future results.

Moderna, Inc. (MRNA) vs Mettler-Toledo International Inc. (MTD)

MTD leads on 7 of 9 compared metrics.

A side-by-side comparison of Moderna, Inc. and Mettler-Toledo International Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Mettler-Toledo International Inc.

$22.86B

$1131.49Healthcare

Total return — MRNA vs MTD

growth of $100 · last 8y

MRNA +165.5%MTD +91.2%MRNA compounded faster

MRNA MTD

MRNA vs MTD: by the numbers

•MTD is the larger company ($22.86B vs $19.80B market cap).
•MTD is profitable (21.40% net margin) while MRNA runs a net loss (-143.55%).
•MTD grew revenue faster over the past five years (4.77% vs -2.60% CAGR).

Which is better, MRNA or MTD?

Metric tally: MRNA 2 · MTD 7

It depends on what you're optimizing for:

GrowthMTD(faster 5Y revenue CAGR)

QualityMTD(higher ROIC)

Valuation

Metric	MRNA	MTD
P/E ratio	—	26.49
Forward P/E	—	22.12
P/S ratio	8.86	5.61●
P/B ratio	2.66	—
PEG ratio	—	8.96
EV / EBITDA	—	20.60
FCF yield	—	3.46%

Profitability

Metric	MRNA	MTD
Gross margin	-13.89%	57.79%●
Operating margin	-153.35%	28.00%●
Net margin	-143.55%	21.40%●
ROE	-43.12%●	-3677.41%
ROIC	-29.70%	35.46%●

Growth (annualized)

Metric	MRNA	MTD
Revenue CAGR (5Y)	-2.60%	4.77%●
EPS CAGR (5Y)	—	10.81%
FCF CAGR (5Y)	126.92%●	1.98%
Total return CAGR (5Y)	-25.58%	-3.11%●

Frequently asked

Which is better, MRNA or MTD?: It depends on your goal. growth: MTD (faster 5Y revenue CAGR); quality: MTD (higher ROIC). Across all compared metrics, MTD leads 7 to 2.
Which has grown faster, MRNA or MTD?: Over the past five years, MTD grew revenue faster — MRNA at a -2.60% CAGR versus MTD at 4.77%.
Is MRNA or MTD more profitable?: MTD runs the higher net margin — MRNA at -143.55% versus MTD at 21.40%.
Which has been the better investment, MRNA or MTD?: Over the past 5-year, MTD delivered the higher annualized total return — MRNA at -25.58% versus MTD at 11.59%. Past performance doesn't predict future results.

Go deeper

Full MRNA analysis Full MTD analysis Interactive comparison tool

Dig into the metrics

Moderna P/E ratio Mettler-Toledo International P/E ratio Moderna dividend yield Mettler-Toledo International dividend yield Moderna ROE Mettler-Toledo International ROE Moderna operating margin Mettler-Toledo International operating margin Moderna revenue growth Mettler-Toledo International revenue growth Moderna free cash flow Mettler-Toledo International free cash flow

Moderna & Mettler-Toledo International appear in these rankings

Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.